In 2012, contaminated medications from the New England Compounding Center (NECC) caused a meningitis outbreak, leading to tragedy when 64 patients were killed and 751 injured. Unsurprisingly, the pharmacy compounding industry has been under close scrutiny ever since. The FDA has now become the primary agency for regulating compounding pharmacies such as NECC. Historically, compounding[…]
How to Stay Compliant in a Changing Pharma Regulatory Landscape
Compounding API Tags: APIblogcomplianceLGM Pharmaqualityregulatory Dec 06, 2019
Behind the Scenes with LGM Pharma’s API Sourcing Team
Drug Research & Development API, LGM Pharma Tags: APICMOLGMpharmaprocurementsourcingteam Oct 02, 2019
Running a marathon is just like what we do here at LGM Pharma – and in more ways than one, as it turns out. First, the obvious: Both API sourcing and marathons are a long game. Marathons are 26.2 miles long (or longer) – and drug development & commercialization (and therefore API sourcing) is measured[…]
9 Key Sourcing Challenges for Small Pharma
Drug Research & Development API, LGM Pharma Tags: APIAPIsDMFDrug Developmentlogisticspharmascale-upsourcingsupply chainvirtual pharma Sep 05, 2019
Pharma and biopharmaceutical supply chains continue to grow more complex & global. The process of sourcing active pharmaceutical ingredients (APIs) and intermediates has also become more challenging. In 2018, ISR Reports looked at how experience and capacity impact small molecule API outsourcing. Among the findings, about 25% of respondents indicated their company lacked the capacity[…]
